Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1: Usage of esketamine spray for treatment-resistant major depressive disorder (MDD)
- Case 2: The man who is confused about his identity
- Case 3: Propane, shattered glass, and parasites
- Case 4: Hit by a car
- Case 5: Caring for the whole person
- Case 6: The man whom clozapine (Clozaril) could not touch
- Case 7: Where did her period go?
- Case 8: To dopamine or not to dopamine, that is the question
- Case 9: The one that came out of nowhere
- Case 10: Darth Vaper strikes again
- Case 11: First-time Mom’s struggle with postpartum post-traumatic stress disorder (PTSD)
- Case 12: Why so down?
- Case 13: It’s confusing, isn’t it?
- Case 14: The adolescent who just can’t stay awake
- Case 15: The lady with bipolar disorder (BP), borderline personality disorder (BPD), and myasthenia gravis (MG)
- Case 16: Spending money does not make a bipolar diagnosis
- Case 17: Pain makes me anxious, and anxiety gives me pain
- Case 18: The woman who couldn’t focus
- Case 19: The gentleman with sudden onset of akathisia on clozapine (Clozaril)
- Case 20: The pregnancy blues
- Case 21: The menopause blues
- Case 22: The lady who felt “funny” on the medication
- Case 23: Two ladies with bruises
- Case 24: The lady who was afraid for her kids
- Case 25: The woman whose kidneys could not handle lithium
- Case 26: The gentleman who was sober and could not focus
- Case 27: When the music does not stop
- Case 28: The man who tried to get it right
- Index of drug names
- Index of case studies
- References
Case 16: - Spending money does not make a bipolar diagnosis
Published online by Cambridge University Press: 03 April 2024
Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies: Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1: Usage of esketamine spray for treatment-resistant major depressive disorder (MDD)
- Case 2: The man who is confused about his identity
- Case 3: Propane, shattered glass, and parasites
- Case 4: Hit by a car
- Case 5: Caring for the whole person
- Case 6: The man whom clozapine (Clozaril) could not touch
- Case 7: Where did her period go?
- Case 8: To dopamine or not to dopamine, that is the question
- Case 9: The one that came out of nowhere
- Case 10: Darth Vaper strikes again
- Case 11: First-time Mom’s struggle with postpartum post-traumatic stress disorder (PTSD)
- Case 12: Why so down?
- Case 13: It’s confusing, isn’t it?
- Case 14: The adolescent who just can’t stay awake
- Case 15: The lady with bipolar disorder (BP), borderline personality disorder (BPD), and myasthenia gravis (MG)
- Case 16: Spending money does not make a bipolar diagnosis
- Case 17: Pain makes me anxious, and anxiety gives me pain
- Case 18: The woman who couldn’t focus
- Case 19: The gentleman with sudden onset of akathisia on clozapine (Clozaril)
- Case 20: The pregnancy blues
- Case 21: The menopause blues
- Case 22: The lady who felt “funny” on the medication
- Case 23: Two ladies with bruises
- Case 24: The lady who was afraid for her kids
- Case 25: The woman whose kidneys could not handle lithium
- Case 26: The gentleman who was sober and could not focus
- Case 27: When the music does not stop
- Case 28: The man who tried to get it right
- Index of drug names
- Index of case studies
- References
Summary
What is the typical rate of conversion from major depressive disorder (MDD) to bipolar I disorder (BP1) over time?
Keywords
generalized anxietypanic disorderagoraphobiadepressionaugmentationalprazolam (Xanax)buspirone (Buspar)citalopram (Celexa)clonazepam (Klonopin)clonidine (Catapres)dexmedetomidine sublingual (Igalmi)duloxetine (Cymbalta)escitalopram (Lexapro)gabapentin (Neurontin)hydroxyzine (Atarax)lamotrigine (Lamictal)lurasidone (Latuda)melatoninolanzapine (Zyprexa)sertraline (Zoloft)suvorexant (Belsomra)trazodone (Desyrel)venlafaxine (Effexor XR)
- Type
- Chapter
- Information
- Case Studies: Stahl's Essential Psychopharmacology , pp. 265 - 282Publisher: Cambridge University PressPrint publication year: 2024
References
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5, 5th edn. Arlington, VA: American Psychiatric Publishing, Inc., 2013Google Scholar
Altman, EG, Hedeker, D, Peterson, JL, et al. The Altman Self-Rating Mania Scale. Biol Psychiatry 1997; 42:948–55CrossRefGoogle ScholarPubMed
Hirschfeld, RM, Williams, JB, Spitzer, RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry 2000; 157: 1873–5CrossRefGoogle ScholarPubMed
Judd, LL, Akiskal, HS, Schettler, PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003; 60:261–9CrossRefGoogle ScholarPubMed
McGlashan, TH. Adolescent versus adult onset of mania. Am J Psychiatry 1988; 145:221–3Google ScholarPubMed
McIntyre, RS, Patel, MD, Masand, PS, et al. The Rapid Mood Screener (RMS): a novel and pragmatic screener for bipolar I disorder. Curr Med Res Opin 2021; 37:135–44CrossRefGoogle ScholarPubMed
Musliner, KL, Østergaard, SD. Patterns and predictors of conversion to bipolar disorder in 91 587 individuals diagnosed with unipolar depression. Acta Psychiatr Scand 2018; 137:422–32CrossRefGoogle Scholar
Schwartz, T. Practical Psychopharmacology: Basic to Advanced Principles, 1st edn. New York: Routledge, 2017CrossRefGoogle Scholar
Tsai, SY, Lee, JC, Chen, CC. Characteristics and psychosocial problems of patients with bipolar disorder at high risk for suicide attempt. J Affect Disord 1999; 52:145–52CrossRefGoogle ScholarPubMed